Role and date, before programme
Sessions 1 and 2 told you which systems are in scope and which are high-risk. Two questions remain before you can plan a single piece of work: what is your role for each system, and when does the clock actually run out? Role decides how much of the compliance burden lands on you versus a partner. The timeline decides how much runway you have. Leaders who answer these two wrongly either do a supplier's work for free or discover a deadline the quarter it lands. This session settles both, and flags a live amendment that could shift the biggest date.
The roles 9 min live
The Act sees AI moving along a supply chain, and it gives each link a name and a set of duties. The names matter because the obligations - and the fines - attach to the role, not to the company in general. Get your role right for each system and you know exactly which duties are yours.
| Role | One line | Key duty |
|---|---|---|
| Provider | Develops it and puts it out under its own name (Art 3, 16) | The full high-risk programme - heaviest load |
| Deployer | Uses the system under its own authority (Art 3, 26) | Use as instructed, keep human oversight, monitor |
| Importer | EU-established, brings a non-EU provider's system in (Art 23) | Check the provider did the conformity work |
| Distributor | Makes the system available down the chain (Art 24) | Verify markings and documentation are present |
| Authorised rep | EU point of contact for a non-EU provider (Art 22, 25) | Hold documentation, liaise with authorities |
LiveWhy the provider carries the most3 min▶
For a high-risk system, the provider (Article 16) owns almost the entire compliance programme:
- Build and run the risk-management system, ensure data governance and technical documentation, keep logs, design human oversight, and hit accuracy and robustness targets.
- Put the system through a conformity assessment, apply CE marking, and register it in the EU database before it goes to market.
- Set up a quality-management system and a post-market monitoring process, and report serious incidents.
The deployer (Article 26), by contrast, has a lighter and more operational set of duties: use the system according to the provider's instructions, assign competent human oversight, monitor how it performs, and keep the logs it generates. Real, but a fraction of the provider's load.
LiveThe Singapore firm is usually the provider3 min▶
A Singapore company that builds an AI product and sells it into the EU under its own brand is the provider - the role with the heaviest obligations - even with no office in Europe. That surprises leaders who assume a distant vendor escapes the burden. It does not; the burden follows the system.
- A customer in the EU who buys and uses that system is the deployer, with its own lighter duties.
- Because the provider sits outside the EU, the Act generally requires it to appoint an authorised representative inside the EU as a point of contact for regulators.
- Watch the reassignment trap: if a deployer substantially modifies a high-risk system or puts its own name on it, that deployer can become a provider and inherit the heavy duties.
Self-studyOne company can hold several roles2 min read▶
It is tempting to think a company is simply "a provider" or "a deployer", but in practice most organisations hold different roles for different systems, and sometimes several roles for a single one. A firm might be the provider of the hiring tool it sells, the deployer of a vendor's customer-service chatbot it runs internally, and the importer of a third system it brings into the EU on someone else's behalf - all at once. This is why the classification work you started in session 1 is per-system, not per-company: there is no single answer to "what is our role", only "what is our role for this system". The practical discipline is to keep a register that names, for every in-scope AI system, both its risk tier and your role, because those two facts together determine the entire set of obligations you carry for it. Do that once and keep it current, and the rest of compliance becomes a matter of executing against a known list rather than rediscovering your exposure each time a regulator or customer asks.
The timeline 8 min live
The Act did not switch on all at once. It entered into force in 2024 and phases its obligations in over three years, worst-first: the banned practices came early, the heavy high-risk duties come later to give providers time to build. Knowing the dates turns compliance from a panic into a plan.
LiveThe dates that bind you3 min▶
The Act phases in like this:
- 1 Aug 2024 - entered into force. The clock starts.
- 2 Feb 2025 - the prohibited practices become enforceable, and the AI-literacy duty applies. The banned list is live first.
- 2 Aug 2025 - GPAI model obligations, the governance structure, and the penalty regime apply.
- 2 Aug 2026 - most of the Act applies, including the Annex III high-risk obligations and the Article 50 transparency duties. This is the big one for most companies.
- 2 Aug 2027 - the high-risk rules for AI embedded in already-regulated products (Annex I) apply.
The logic is worst-first: the most dangerous uses were shut down earliest, and the heavy high-risk programme lands later so providers have time to build it. For a typical high-risk system, 2 Aug 2026 is the date to plan around.
LiveThe live delay you should track3 min▶
As this course is written, the EU has proposed an amendment package - informally the "Digital Omnibus" - that would push the heaviest deadlines back:
- Annex III high-risk obligations may move from 2 Aug 2026 to around 2 Dec 2027.
- Annex I embedded high-risk obligations may move to 2 Aug 2028.
- The package has also floated adding a ninth prohibited practice to the Article 5 banned list.
Vantage plans to 2026, watches 2027. Vantage is the provider of a high-risk hiring tool, so its baseline deadline for the full programme is 2 Aug 2026. Its board asked the obvious question: if the delay is coming, why not wait? Because the delay is proposed, not law, and because a German customer already asked for conformity documentation. Vantage plans and builds to the original 2026 date, treats any confirmed delay as breathing room rather than a reason to stop, and keeps a standing item to re-verify the dates before each milestone.
Self-studyWhy the dates run worst-first2 min read▶
The staggered timeline is not bureaucratic randomness; it follows a deliberate logic that helps you predict where regulators will focus. The uses the Act judges simply unacceptable - the Article 5 banned practices - were switched off first, only six months after entry into force, because there is nothing to build or phase in: you just stop. The general-purpose model rules and the governance and penalty machinery came next, because the ecosystem needed the enforcement structure and the foundation-model layer settled before the heavy product-level duties landed. The full high-risk programme was given the longest runway because it is genuinely hard to build - a risk-management system, data governance, technical documentation, human oversight, a conformity assessment - and rushing providers into it would have produced paper compliance rather than real safety. For a leader, the practical read is this: enforcement attention tracks the calendar. The banned list is already live and already enforced, so a prohibited use is your most acute exposure today, while the high-risk programme is a build-it-properly project you should be resourcing now against a 2026 or 2027 date. Knowing the order lets you sequence your own work to match the regulator's.
Name your role for each system ★ 12 min · pen and paper
Take the in-scope systems from session 1 and pin a role to each.
List each in-scope system and ask the first question: did we build it and put it out under our own name? If yes, you are the provider - the heavy role.
If we merely use a vendor's system under our own authority, you are the deployer. Note it, and note whether you have modified it (which could push you back to provider).
If you are a non-EU provider, flag that you likely need an authorised representative in the EU, and note who that might be.
Build a two-column register: system to the left, tier-and-role to the right. That register is the backbone of everything the rest of the course asks you to do.
Place your systems on the timeline ★ 8 min · your next AI review
Turn the dates into deadlines you own.
"Do we run any prohibited practice?" If yes, the deadline already passed (2 Feb 2025) - that is a stop-now item, not a plan-for item.
"Do we provide or use a GPAI model?" Those obligations applied from 2 Aug 2025 - check you are current, not future-planning.
"For each high-risk system, is it standalone (Annex III) or embedded in a regulated product (Annex I)?" That decides 2 Aug 2026 versus 2 Aug 2027.
"What is our earliest binding date, and how much runway is left?" Mark it on the calendar, then note the proposed Digital Omnibus delay beside it as possible relief - and set a reminder to re-verify.
Before session a4 ◐ 30 min total
- Complete the tier-and-role register for every in-scope system - a4 covers the penalties that make getting this right worth the effort.
- For each high-risk system, write down its binding date (2026 standalone, 2027 embedded) and note the proposed delay beside it.
- If you are a non-EU provider, find out whether you have - or need - an authorised representative in the EU.
- Optional: skim Articles 16 (provider duties) and 26 (deployer duties) so the split is concrete for your team.
- For each in-scope system, are we the provider, the deployer, the importer, or the distributor?
- Have we substantially modified or re-branded any vendor system - and could that make us the provider?
- As a non-EU provider, do we have an authorised representative in the EU, or do we need one?
- What is the binding application date for each of our high-risk systems - 2 Aug 2026 or 2 Aug 2027?
- Are we planning to the original dates, and are we tracking the Digital Omnibus delay to re-verify before each milestone?
Official sources covered
Taught from the primary texts. This page covers:
Three questions before you go 🎯 ◐ 90 seconds
1 · Vantage builds its AI hiring tool in Singapore and sells it into the EU under its own brand. Its EU AI Act role is...
A company that develops a system and places it on the market under its own name is the provider (Art 3, 16) - the heaviest role - regardless of where it sits. It will also likely need an EU authorised representative.
2 · For most companies, the key deadline when standalone high-risk (Annex III) obligations apply is...
Most of the Act, including the Annex III high-risk obligations and Article 50 transparency duties, applies from 2 Aug 2026. The proposed Digital Omnibus delay may push this to around Dec 2027 - plan to the earlier date.
3 · A deployer buys a high-risk system, then substantially modifies it and puts its own name on it. The likely result is...
Substantially modifying a high-risk system or putting your own name on it can make you the provider, inheriting the full Article 16 programme. Role follows what you do to the system, not your industry.